Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.

Journal of Neurology
Heidi J SalminenMike Boggild

Abstract

With the increasing incidence of multiple sclerosis (MS) in women and the earlier use of disease modifying therapy (DMT), issues surrounding DMT and pregnancy are a regular subject of discussion with regards to optimal management. Current recommendations are to withdraw DMT prior to conception, leaving patients exposed to an uncertain period of untreated disease. The objective of this study is to report preliminary experience on glatiramer acetate (GA) exposure through conception, pregnancy and the post-partum period in a series of 13 patients with previously highly active relapsing-remitting MS. This is a prospective observational case series. Fourteen pregnancies of 13 women resulted in 13 live births (one twin pregnancy), nine exposed to GA throughout pregnancy. There were no birth defects and treatment was well tolerated. No relapses occurred during pregnancy in those continuing on treatment. In conclusion, our early experience suggests that when considering the risks and benefits of treatment withdrawal prior to pregnancy, it may be reasonable to continue GA in those patients with previously highly active disease. Consideration should also be given to the initiation of a birth register, similar to such initiatives in epile...Continue Reading

References

Jul 31, 1998·The New England Journal of Medicine·C ConfavreuxT Moreau
May 8, 2004·Brain : a Journal of Neurology·Sandra VukusicUNKNOWN Pregnancy In Multiple Sclerosis Group
Oct 20, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·N AdabD W Chadwick
Apr 1, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·M SarasteL Airas
Nov 18, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·M Lee, P O'Brien
Aug 21, 2009·Multiple Sclerosis : Clinical and Laboratory Research·C Weber-Schoendorfer, C Schaefer

❮ Previous
Next ❯

Citations

Aug 29, 2012·Journal of Neurology·Maria K Houtchens, Channa M Kolb
Oct 21, 2011·Current Opinion in Obstetrics & Gynecology·Alex Tsui, Martin A Lee
Nov 19, 2011·Multiple Sclerosis International·Mona Alkhawajah, Joel Oger
Apr 2, 2014·Revue neurologique·E BodiguelJ De Seze
Jul 5, 2012·Women's Health·Sura Alwan, A Dessa Sadovnick
May 1, 2015·Expert Review of Neurotherapeutics·Aaron L BosterYossi Gilgun-Sherki
Nov 20, 2014·Expert Opinion on Drug Safety·Patricia K Coyle
Jun 30, 2012·Medicina clínica·Carmen TurCristina Aguilera
May 29, 2012·Clinical Neurology and Neurosurgery·Yara Dadalti FragosoClaudia Cristina Ferreira Vasconcelos
Jul 31, 2012·Neurologic Clinics·P K Coyle
Jan 10, 2012·Annals of the New York Academy of Sciences·Shiv SaidhaPeter A Calabresi
Mar 31, 2015·La Presse médicale·Laure MichelAlexandre Prat
Mar 20, 2015·Multiple Sclerosis and Related Disorders·Sura AlwanA Dessa Sadovnick
Jan 13, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Sandra HerbstrittKerstin Hellwig
Jun 27, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Pamela A McCombe, Judith M Greer
Mar 24, 2017·Expert Opinion on Drug Safety·Jan ThöneKerstin Hellwig
Mar 22, 2013·Revista brasileira de epidemiologia = Brazilian journal of epidemiology·Yara Dadalti FragosoRebeca Recupero Rebs
Sep 15, 2011·Multiple Sclerosis : Clinical and Laboratory Research·E LuH Tremlett
Apr 14, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Michael Hutchinson
May 3, 2016·Therapeutic Advances in Neurological Disorders·Patricia K Coyle
Oct 9, 2012·Expert Review of Neurotherapeutics·Mohsen Khoshnam, Mark S Freedman
Mar 7, 2018·International Journal of MS Care·Magnhild Sandberg-WollheimPatricia K Coyle
Jan 13, 2017·Multiple Sclerosis International·Raed AlroughaniSaeed Bohlega
Sep 1, 2012·Obstetric Medicine·Laura Airas, Risto Kaaja
Jul 14, 2020·Therapeutic Advances in Neurological Disorders·Kristen M KryskoKerstin Hellwig
Aug 2, 2020·Revue neurologique·S VukusicC Lebrun-Frenay
Apr 6, 2021·Current Treatment Options in Neurology·Kristen M KryskoKerstin Hellwig
May 18, 2021·Frontiers in Neurology·Simona BonavitaDominic Jack
Aug 14, 2021·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Borros M Arneth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

© 2021 Meta ULC. All rights reserved